SSTI

Question 1

Mild nonpurulent SSTI treatment

Answer 1

ORAL

• Penicillin VK
• Cephalosporin
• Clinda

Question 2

Moderate nonpurulent SSTI treatment

Answer 2

IV

• Pen
• Ceftriaxone
• Cefazolin
• Clinda

Question 3

Severe nonpurulent SSTI treatment

Answer 3

• Empiric Rx (Vanco + pip/tazo)

- Defined Rx (Pen + clinda)

Question 4

Mild purulent SSTI treatment

Answer 4

I&D

Question 5

Moderate purulent SSTI treatment

Answer 5

• I&D
• Empiric: (Bactrim or Doxy)
• Defined: MRSA (Bactrim); MSSA (Cephalexin)

Question 6

Severe purulent SSTI treatment

Answer 6

• I&D
• Empiric (Vanco or Dapto or Linezolid)
• Defined: MRSA (empiric); MSSA (Nafcillin, clinda)

Question 7

Purulent S. aureus ifection

Answer 7

• MRSA (cover empirically)
  
  • IV: Vanco, Dapto
  • Oral: Bactrim, doxy, linezolid
• MSSA (de-escalate)
  
  • IV: Amp/sulb, Naf/Oxa
  • Oral: Augmentin, clinda, cephalexin

Question 8

SIRs criteria

Answer 8

• Temp > 38 degrees or < 36 degrees
• Tachypnea >24 breaths/min
• Tachycardia >90 beats/min
• WBC >12,000 or <4,000 cells

Question 9

Bite wound treatment

Answer 9

Amp/sulb (IV) or Augmentin

Question 10

DFI Classification

Answer 10

• Erythema > 0.5 cm < 2 cm (mild)
• Erythema > 2 cm or involving structures deeper then skin (moderate)
• Local infection with > 2 SIRS criteria (severe)

Question 11

Mild DFI

Answer 11

• MSSA (cephalexin, Augmentin, Clinda)

- MRSA (Bactrim, doxy)

Question 12

Moderate or Severe DFI

Answer 12

• MSSA (Unasyn)
• MRSA (vanco, linezolid, dapto)
• Pseudomonas (pip/tazo,cefepime)